Jackie Hunter shares her views on the future applications of AI in pharma.

Does pharma have the right mindset when it comes to adopting and implementing AI more widely?

COVID-19 vaccine rollout is a lottery, with some countries faring much better than others.

Can drug delivery be redefined using polymeric threads?

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"

Lori Muffly believes collaboration and innovation – bolstered during the COVID-19 pandemic – will guide the future of stem cell transplant.

Is waiving patents for COVID-19 vaccines the right step forward?

If the industry can figure out 3D printing’s regulatory hurdles, we may be on the cusp of a revolution: the democratization of personalized precision.

AI opens up new opportunities in R&D – and also provides pharma companies with new ways to connect with patients for better outcomes.

We speak with G-CON’s Maik Jornitz about his career and desire to give back by training the next generation.